4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000137
Director sold 21,332 shares at an average $79.51 ($1,696,181)
- Director acquired 16,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
KLEIN JOSEPH III · Director
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-03 | Exercise or conversion : show line 1 in the form 10b5-1 | +12,000 | $40.05 | $480,600 | 28,346 | D |
| 2026-03-03 | Exercise or conversion : show line 2 in the form 10b5-1 | +4,000 | $42.88 | $171,520 | 32,346 | D |
| 2026-03-03 | Sale : show line 3 in the form 10b5-1 | −13,526 | $79.17 | $1,070,908 | 18,820 | D |
| 2026-03-03 | Sale : show line 4 in the form 10b5-1 | −6,794 | $80.00 | $543,486 | 12,026 | D |
| 2026-03-03 | Sale : show line 5 in the form 10b5-1 | −1,012 | $80.82 | $81,788 | 11,014 | D |
| Open-market sales · 21,332 sh · avg $79.51 · $1,696,181 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-03 | Exercise or conversion : show line 6 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −12,000 | 0 | D |
| 2026-03-03 | Exercise or conversion : show line 7 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −4,000 | 0 | D |
Loading xslF345X05/edgardoc.xml…